Blockchain Registration Transaction Record

Nutriband Partners with Brand Institute for Abuse-Deterrent Fentanyl Patch

Nutriband partners with Brand Institute to develop branding for AVERSA FENTANYL, the world's first abuse-deterrent opioid patch using innovative transdermal technology.

This development represents a crucial advancement in addressing the ongoing opioid crisis that has devastated communities worldwide. The creation of an abuse-deterrent fentanyl patch could significantly reduce prescription opioid misuse, which currently accounts for thousands of overdose deaths annually. For patients requiring strong pain management, this technology offers the therapeutic benefits of fentanyl while incorporating safety features that prevent extraction, injection, or other forms of misuse. Healthcare providers gain a new tool to manage severe pain while minimizing diversion risks, and regulatory agencies see progress in combating the opioid epidemic through technological innovation rather than just restriction. The involvement of former FDA and international regulatory officials in the branding process suggests strong confidence in the product's regulatory pathway and market potential.